Literature DB >> 16802322

Enhanced activation of Ca2+/calmodulin-dependent protein kinase II upon downregulation of cyclin-dependent kinase 5-p35.

Tomohisa Hosokawa1, Taro Saito, Akiko Asada, Toshio Ohshima, Makoto Itakura, Masami Takahashi, Kohji Fukunaga, Shin-Ichi Hisanaga.   

Abstract

Cyclin-dependent kinase 5 (Cdk5)-p35 is downregulated in cultured neurons by N-methyl-D-aspartate (NMDA) via the proteasomal degradation of p35. However, it is not known where in neurons this downregulation occurs or the physiologic meaning of the reaction. We show the enrichment of Cdk5 and p35 in the postsynaptic density and the NMDA-induced degradation of postsynaptic p35 using brain slices and cultured neurons. To evaluate the role of this downregulation, we examined the relationship between Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) activation and Cdk5 downregulation, as events downstream from NMDA stimulation. Glutamate or NMDA stimulation induced CaMKII autophosphorylation over a time course that mirrored the time course of p35 degradation. To simulate the downregulation of postsynaptic Cdk5 in invitro experiments, we used the Cdk5 inhibitor roscovitine. The inhibition of Cdk5 activity by roscovitine enhanced CaMKII autophosphorylation and activation in cultured neurons, and in an isolated postsynaptic-density-enriched fraction. These results suggest that Cdk5 activity suppresses CaMKII activation, and that the downregulation of Cdk5 activity after treatment withNMDA facilitates CaMKII activation, leading to the easier induction of long-term potentiation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16802322     DOI: 10.1002/jnr.20975

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  19 in total

1.  Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE.

Authors:  Tomohisa Hosokawa; Taro Saito; Akiko Asada; Kohji Fukunaga; Shin-Ichi Hisanaga
Journal:  Mol Cell Proteomics       Date:  2010-01-23       Impact factor: 5.911

2.  Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia.

Authors:  Adam J Funk; Robert E McCullumsmith; Vahram Haroutunian; James H Meador-Woodruff
Journal:  Neuropsychopharmacology       Date:  2011-11-02       Impact factor: 7.853

3.  Activity-dependent phosphorylation of neuronal Kv2.1 potassium channels by CDK5.

Authors:  Oscar Cerda; James S Trimmer
Journal:  J Biol Chem       Date:  2011-06-28       Impact factor: 5.157

4.  Molecular Roles of Cdk5 in Pain Signaling.

Authors:  Elias Utreras; Akira Futatsugi; Tej Kumar Pareek; Ashok B Kulkarni
Journal:  Drug Discov Today Ther Strateg       Date:  2009-09

Review 5.  The role of Cdk5 in cognition and neuropsychiatric and neurological pathology.

Authors:  David G S Barnett; James A Bibb
Journal:  Brain Res Bull       Date:  2010-12-07       Impact factor: 4.077

6.  Familial hemiplegic migraine Ca(v)2.1 channel mutation R192Q enhances ATP-gated P2X3 receptor activity of mouse sensory ganglion neurons mediating trigeminal pain.

Authors:  Asha Nair; Manuela Simonetti; Nicol Birsa; Michel D Ferrari; Arn M J M van den Maagdenberg; Rashid Giniatullin; Andrea Nistri; Elsa Fabbretti
Journal:  Mol Pain       Date:  2010-08-24       Impact factor: 3.395

7.  CDK5 downregulation enhances synaptic plasticity.

Authors:  Rafael Andrés Posada-Duque; Omar Ramirez; Steffen Härtel; Nibaldo C Inestrosa; Felipe Bodaleo; Christian González-Billault; Alfredo Kirkwood; Gloria Patricia Cardona-Gómez
Journal:  Cell Mol Life Sci       Date:  2016-08-09       Impact factor: 9.261

8.  Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.

Authors:  Toshiyuki Takasugi; Seiji Minegishi; Akiko Asada; Taro Saito; Hiroyuki Kawahara; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2015-12-02       Impact factor: 5.157

9.  A pathway map of glutamate metabolism.

Authors:  Soujanya D Yelamanchi; Savita Jayaram; Joji Kurian Thomas; Seetaramanjaneyulu Gundimeda; Aafaque Ahmad Khan; Anish Singhal; T S Keshava Prasad; Akhilesh Pandey; B L Somani; Harsha Gowda
Journal:  J Cell Commun Signal       Date:  2015-12-03       Impact factor: 5.782

10.  Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer's disease.

Authors:  Laura T Haas; Santiago V Salazar; Mikhail A Kostylev; Ji Won Um; Adam C Kaufman; Stephen M Strittmatter
Journal:  Brain       Date:  2015-12-14       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.